Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126397701 | 12639770 | 1 | I | 20160726 | 20160810 | 20160810 | PER | US-AMGEN-USASP2016098730 | AMGEN | 71.00 | YR | E | F | Y | 0.00000 | 20160810 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126397701 | 12639770 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126397701 | 12639770 | 2 | SS | ADALIMUMAB | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126397701 | 12639770 | 3 | SS | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126397701 | 12639770 | 4 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Unknown | UNK | 0 | ||||||||||
| 126397701 | 12639770 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 126397701 | 12639770 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 126397701 | 12639770 | 7 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, BID | 0 | 150 | MG | BID | |||||||
| 126397701 | 12639770 | 8 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 7 MG, QWK | 0 | 7 | MG | /wk | |||||||
| 126397701 | 12639770 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, QD | 0 | 81 | MG | QD | ||||||||
| 126397701 | 12639770 | 10 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | Q6H, 5-325MG | 0 | QID | |||||||||
| 126397701 | 12639770 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 175 MUG, UNK | 0 | 175 | UG | ||||||||
| 126397701 | 12639770 | 12 | C | NALOXEGOL OXALATE. | NALOXEGOL OXALATE | 1 | Oral | 25 MG, QWK | 0 | 25 | MG | /wk | |||||||
| 126397701 | 12639770 | 13 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126397701 | 12639770 | 14 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 126397701 | 12639770 | 15 | C | AZULFIDINE | SULFASALAZINE | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 126397701 | 12639770 | 16 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Subcutaneous | 6 MG, BID | 0 | 6 | MG | BID | |||||||
| 126397701 | 12639770 | 17 | C | DESYREL | TRAZODONE HYDROCHLORIDE | 1 | Oral | 150 MG, BEDTIME | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126397701 | 12639770 | 1 | Product used for unknown indication |
| 126397701 | 12639770 | 2 | Product used for unknown indication |
| 126397701 | 12639770 | 3 | Product used for unknown indication |
| 126397701 | 12639770 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126397701 | 12639770 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |